Skip to content

FLUOCOL-1 : Intraoperative Indocyanine Green Fluorescence Angiography in Colorectal Surgery to Prevent Anastomotic Leakage

Status
Not yet recruiting
Phases
Phase 3Phase 4
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2024-515118-42-00
Enrollment
1010
Registered
2024-09-10
Start date
Unknown
Completion date
Unknown
Last updated
2026-01-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal cancer

Brief summary

The primary endpoint is the occurrence of an anastomotic leakage 90-days post-operation. Anastomotic leakage is defined as any anastomotic dehiscence with leakage into the pelvic cavity diagnosed upon imaging or at surgical exploration or any isolated pelvic organ-space infection with no evidence of fistula as defined by the International Study Group of Rectal Cancer

Detailed description

Change in planned anastomosis during surgery defined as any decision change upon perfusion assessment such as modifying the initially planned transection level of the descending colon or refashioning anastomosis including the decision to undertake a permanent stoma rather than an anastomosis, Rate of defunctioning stoma, Overall 90-day postoperative morbidity, including all complications according to the Clavien-Dindo classification, and occurring within 90 days after surgery, Postoperative mortality, including all deaths occurring within 90 days after surgery, Duration of hospital stay, calculated from the day of surgery to the day of hospital discharge, Postoperative reintervention within 90 days, HRQoL using the QLQ-C30 and QLQ-CR29 at baseline and 90 days post-operation, Medico-economic interest of IOFA with ICG use

Interventions

Sponsors

Centre Hospitalier Regional Universitaire
Lead SponsorOTHER

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Design outcomes

Primary

MeasureTime frame
The primary endpoint is the occurrence of an anastomotic leakage 90-days post-operation. Anastomotic leakage is defined as any anastomotic dehiscence with leakage into the pelvic cavity diagnosed upon imaging or at surgical exploration or any isolated pelvic organ-space infection with no evidence of fistula as defined by the International Study Group of Rectal Cancer

Secondary

MeasureTime frame
Change in planned anastomosis during surgery defined as any decision change upon perfusion assessment such as modifying the initially planned transection level of the descending colon or refashioning anastomosis including the decision to undertake a permanent stoma rather than an anastomosis, Rate of defunctioning stoma, Overall 90-day postoperative morbidity, including all complications according to the Clavien-Dindo classification, and occurring within 90 days after surgery, Postoperative mortality, including all deaths occurring within 90 days after surgery, Duration of hospital stay, calculated from the day of surgery to the day of hospital discharge, Postoperative reintervention within 90 days, HRQoL using the QLQ-C30 and QLQ-CR29 at baseline and 90 days post-operation, Medico-economic interest of IOFA with ICG use

Countries

France

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026